Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness
Clinical trial NCT06796361 · RECRUITING
Trial details
- NCT number
- NCT06796361
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-21
- Primary completion
- 2026-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.